>>Hey, everyone, Thanks for taking them to join the story. Hope you and your loved ones are safe during these tough times. Let me start by introducing myself. My name is Michelle. When I walk for GlaxoSmithKline, GSK as an engineering manager in my current role, A little protocol platform A P s, which is part of the already data platform here in G S, K R and D Tech. I live in Dallas, Texas. I have a Masters degree in computer science on a bachelor's in electronics and communication engineering. I started my career as a software developer on over these years again a lot of experience in leading and building, not scale and predicts products and solutions. I also have a complete accountability for container platforms here at GSK or any tick. I've been working very closely with Dr Enterprise, which is no Miranda's for more than three years to enable container platforms that yes, came on mainly in our own Itek. So that's me. Let >>me give you a quick overview on agenda for today's talk. I'll start with what we do here at GSK on what is RND data platform. Then I'll give you an overview on What are the business drivers that >>motivated US toe? Take this container Germany on some insight into learnings on accomplishments over these years. Working with Dr Enterprise on the container platforms Lately, you must have seen a lot of articles off there which talk about how ts case liberating technologies like artificial intelligence, mission learning, UN data and analytics for the Douglas Corey process. I'm very excited to see the progress we have made in technology, but what makes us truly unique is our commitment to the patient. >>We're G escape, help millions of people, do more, feel better and live longer. Wear a global company that is focused on three were tickles pharmaceuticals vaccines on consumer healthcare. Our main intent is to lower the >>burden on the impact of diseases on the patients. Here at GSK, we allow science to drive the technology. This helps us toe build innovative products. That's helps our scientists to make better and faster additions throughout the drug discovery by plane. >>With that, let me give you some >>context on what currently data platform is how it is enabled. A T escape started in mid 2016. What used to be called us are any information platform whose main focus was to centralize curate on rationalized all the data produced within the others are in the business systems in orderto drive, a strategic business value, standardization of clinical trials, Genome Wide Association Study Analysis, also known as Jesus Storage and Crossing Off Rheal. World Evidence data some of the examples off how the only platform was used to deliver the business value four years later. No, a new set off business rivals of changing our landscape. The irony Information Platform is evolving to be a hybrid, multi cloud solution and is known as already did a platform refering to 20 >>19 GSK's annual report. These are the four teams that there are any platform will be mainly focused on. We're expanding our data capabilities to support the use. Escape by a former company on evolving into a hybrid medical platform is one of the many steps that we're taking to be future ready. Our key focus will still be making >>greater recommendations better and faster by using that wants us. We're making the areas like artificial intelligence and machine learning. No doc brings us toe. What is Germany is important. Why are we taking this German with that? Let me take you to the next topic off. Like the process of discovery, Francisco is not an easy process. Talking about the recent events occurred over the last few months on the way. How all our lives are impacted. It is a lot of talk on information going about. Why did drug discovery process is so tough working for a global health care company? I get asked this question very frequently. From many people I interact with. Question is like, Why is that? This car is so tough on why it takes so much time. Drug discovery is a complex process that involves multiple different stages on at each and every stage. There is huge amounts of data that the scientists have took process to make some decisions. Studies have shown that only 3% off small molecules entering the human studies actually become medicines. If you're new to drug discovery, you may ask, like what is the targets? Targets so low? We humans are very complex species, >>not going into the details of the process. We're G escape >>have made a lot of investments into technology that enabled us to make data river conditions. Throw the drug Discovery pipeline >>as we implement. As we started implementing these tools and technologies to enable already did a platform, we started to get a better appreciation off how these tools in track on integrate >>with each other. Our goal wants to make this platform a jail, the platform that can work at scale so that we can provide a great user experience and contribute back to the bread discovery pipeline so that the scientists can make faster editions. We want our ardently users to consume the data, and the service is available on the platform seamlessly in a self service fashion. And we also have to accomplish this by establishing trust. And then we have to end also enable the academic partnerships, acquisitions, collaborations that DSK has, which actually brings a lot of data on value to our scientists. So when we talk about so many collaborations and a lot of these systems, what this brings in is wide range off systems and platforms that are fundamentally built on different infrastructure. This is where Doctor comes into fiction on our containers significance. >>We have realized the power of containers on how we can simplify this complex ecosystem by using containers and provide a faster access off data to war scientists who didn't go >>back and contribute back to the drug discovery by play. >>With that, let me take talk to you about >>the containers journey and she escaped. So we started our container journey in late 2017. We started working with Dr Enterprise to enable the container platform. This is on our on prem infrastructure Back then, or first year or so we walked through multiple Pelosis did a lot of testing to make sure our platform is stable before we onboard either the data or the user applications. I was part of this complete journey on Dr Stream has worked with us very closely towards you. The first milestone off establishing a stable container platform. A tsk. Now, getting into 2019 we started deploying our applications in production environment. I cannot go into the details of what this Absar, but they do include both data pipelines as well as Web services. You know, initial days we have worked a lot on swamp, but in 2019 is when we started looking into communities in the same year, we enable kubernetes orchestration on the doctor and replace platform here at GSK and also made it as a de facto orchestra coming into 2020. All our micro service applications are undead. A pipelines are migrated to the container platforms on all of these are orchestrated by Cuban additional on these air applications that are running in production. As of today, we have made the container forced approach as an architectural standard across already taking GSK. We also started deploying our AML training models onto containers on All this work is happening on our Doctor Enterprise platform. Also as part off are currently platforms hybrid multicolored journey. We started enabling container and kubernetes based platforms on public clubs. Now going into 2021 on future. Enabling our RND users to easily access data and applications in a platform agnostic way is very crucial for our success because previously we had only onto him. Now we have public clothes that are getting involved on One of >>the many steps we're taking through this journey is to >>watch allies the data on ship data and containers or kubernetes volumes on demand to our our end users of scientists. And this allows us to deliver data to our scientists wherever they want in a very security on. We're leveraging doctor to do it. So that's >>our future. Learning on with that, let's take a deep dive into fuel for >>our accomplishments over these years. I want to start with a general demand and innovative one very interesting use case that we developed on Dr. This is a rapid prototyping capability that enabled our scientists seamlessly to Monday cluster communication. This was one off the biggest challenges which way his face for a long time and with the help of containers, were able to solve this on provide this as a capability to our scientists. We actually have shockers this capability in one of the doctor conferences before next. As I've said before, by migrating all over web services into containers, we not only achieved horizontal scalability for those specific services, but also saved more than 50% in support costs for the applications which we have migrated by making Docker image as an immutable artifact In our bill process, we are now able to deploy our APS or models in any container or Cuban, its base platform, either in on Prem or in a public club. We also made significant improvements towards the process. A not a mission By leveraging docker containers, containers have played a significant role in keeping US platform agnostic and thus enabling our hybrid multi cloud Germany valuable for out already did scientists. As I mentioned before, data virtualization is another viewpoint we have in terms off our next steps off where we want to take kubernetes on where we wanna leverage open it. Us. What you see here are just a few off many accomplishments which we have our, um, achieved by using containers for the past three years or so. So with that before I close all the time and acknowledge all our internal partners who has contributed a lot to this journey mainly are in the business are on the deck on the broader take. Organizations that escape also want to time document present Miranda's for being such a great partner throughout this journey and also giving us an opportunity to share this success story today. Lastly, thanks for everyone to listening to the stop and please feel free to reach out. If you have any questions or suggestions, let's be fit safe. Thank you